Beyond Conventional Immune Checkpoint Inhibition: Renal Cell Carcinoma at the Forefront of Solid Tumor Immunology

The management of advanced renal cell carcinoma (RCC) has been transformed by the development of immune checkpoint inhibitors (ICIs), but still most RCC patients do not receive durable clinical benefit. Importantly, RCC differs substantially from other immunotherapy-responsive solid tumors – it has...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Nat Rev Clin Oncol
Asıl Yazarlar: Braun, David A., Bakouny, Ziad, Hirsch, Laure, Flippot, Ronan, Van Allen, Eliezer, Wu, Catherine J., Choueiri, Toni K.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8317018/
https://ncbi.nlm.nih.gov/pubmed/33437048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41571-020-00455-z
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller